MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-17-0093529
Roris Pharmaceuticals Private Limited
Roris Pharmaceuticals Private Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.71 Cr
▼ 8% YoY
Net profit · FY 2025
₹7.85 Lakh
Net margin 2.9%
EBITDA · FY 2025
₹36.38 Lakh
EBITDA margin 13.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹40 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Roris Pharmaceuticals Private Limited
Data last updated:
Roris Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U51909RJ2019PTC063618. Its GSTIN is 08AAJCR3584J1ZU (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Upendra Sharma and Kamal Kumar Saini.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 48 Shyam Puri Kalwar Road Jhotwara, Jaipur, Rajasthan, India – 302012.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.71 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹7.85 Lakh (net margin 2.9%) and EBITDA of ₹36.38 Lakh (EBITDA margin 13.4%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 15% over five years.
As per MCA filings, the company has open charges of ₹40 Lakh on record.
Roris Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0093529). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Roris Pharmaceuticals Private Limited
CIN U51909RJ2019PTC063618
Registration Number 063618
Incorporation Date 14 January 2019
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0093529
Recognitions & Rankings of Roris Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address48 Shyam Puri Kalwar Road Jhotwara, Jaipur, Rajasthan, India – 302012
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Roris Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Roris Pharmaceuticals Private Limited
The main business activity of Roris Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Roris Pharmaceuticals Private Limited FY 2025 filings available
Roris Pharmaceuticals Private Limited reported revenue of ₹2.71 Cr (down 8% YoY) for FY 2025.
Revenue · FY 2025
₹2.71 Cr ▼ 8%
Net profit · FY 2025
₹7.85 Lakh margin 2.9%
EBITDA · FY 2025
₹36.38 Lakh margin 13.4%
Compounded Annual Growth Rate (CAGR) of Roris Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 8%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 34%
5 years · compounded
▲ 38%
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Roris Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹36.38 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7.85 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Roris Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Roris Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Roris Pharmaceuticals Private Limited
Roris Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Upendra Sharma Also directs: Uks Health Care Private Limited | Director | 14 Jan 2019 | 7 Years 9 Months | Current |
| Kamal Kumar Saini Also directs: Uks Health Care Private Limited | Director | 14 Jan 2019 | 7 Years 9 Months | Current |
Peer Comparison of Roris Pharmaceuticals Private Limited
Roris Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zedrock Technologies and Pharmaceuticals Private Limited | ₹2.73 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Allahabad, Uttar Pradesh, India |
| Peelife Pharmaceuticals Private Limited | ₹2.73 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Noretsa Pharmaceuticals Private Limited | ₹2.73 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Thrissur, Kerala, India |
| Sanket Pharmaceuticals Pvt Ltd | ₹2.71 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Mumbai, Maharashtra, India |
| Evasteo Pharmaceuticals Private Limited | ₹2.71 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Perinthalmanna, Kerala, India |
| Roris Pharmaceuticals Private Limited this company | ₹2.71 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Jaipur, Rajasthan, India |
| Balaark Pharmaceuticals Private Limited | ₹2.7 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Pune, Maharashtra, India |
| Asv Pharmaceuticals Private Limited | ₹2.7 Cr (FY 2024) | •••• | •••• | 52.0% | •••• | Bangalore, Karnataka, India |
| Techmed Pharmaceuticals Private Limited | ₹2.69 Cr (FY 2025) | •••• | •••• | 4452.0% | •••• | New Delhi, Delhi, India |
| Andromeda Pharmaceuticals Private Limited | ₹2.69 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Indore, Madhya Pradesh, India |
| Futurelife Pharmaceuticals Private Limited | ₹2.69 Cr (FY 2019) | •••• | •••• | 50.0% | •••• | Vadodara, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Roris Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Roris Pharmaceuticals Private Limited
Roris Pharmaceuticals Private Limited is audited by PARAKH & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PARAKH & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Roris Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Roris Pharmaceuticals Private Limited
Open charges
₹40 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Aug 2022 | Hdfc Bank Limited | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Roris Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Roris Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Roris Pharmaceuticals Private Limited
Roris Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Kamal Kumar Saini was appointed as Director on 14 Jan 2019.
AGM
Roris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Roris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 40.00 Lakh with Charge ID 100642778 was registered on 25 Aug 2022.
Appointed
Kamal Kumar Saini was appointed as Director.
Appointed
Upendra Sharma was appointed as Director.
Incorporation
14 Jan 2019
Roris Pharmaceuticals Private Limited was registered on 14 Jan 2019 with Roc Jaipur & aged 7 years 9 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Roris Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Roris Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Roris Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Roris Pharmaceuticals Private Limited
Roris Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAJCR3584J1ZU | Rajasthan | Active | 20 Jan 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Roris Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Roris Pharmaceuticals Private Limited
Roris Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 January 2019 (7+ years old) and is registered under CIN U51909RJ2019PTC063618.
Roris Pharmaceuticals reported revenue of ₹2.71 Cr for FY 2025 (down 8% YoY).
Roris Pharmaceuticals has 2 current directors:
- Upendra Sharma - Director
- Kamal Kumar Saini - Director
Roris Pharmaceuticals reported a net profit of ₹7.85 Lakh (net margin 2.9%) and EBITDA of ₹36.38 Lakh (EBITDA margin 13.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Roris Pharmaceuticals is 8% over three years and 15% over five years. In the latest year (FY 2025) revenue fell 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Roris Pharmaceuticals is 08AAJCR3584J1ZU, registered in Rajasthan.
The CIN (Corporate Identification Number) of Roris Pharmaceuticals is U51909RJ2019PTC063618. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Roris Pharmaceuticals was incorporated on 14 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Roris Pharmaceuticals by revenue are Zedrock Technologies and Pharmaceuticals Private Limited, Peelife Pharmaceuticals Private Limited, Noretsa Pharmaceuticals Private Limited, Sanket Pharmaceuticals Pvt Ltd, Evasteo Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Kamal Kumar Saini was appointed as Director on 14 Jan 2019. Upendra Sharma was appointed as Director on 14 Jan 2019.
Yes, Roris Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0093529).